Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial-Reference-Cited by-同舟云学术

Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial

Published:2019-01 Issue:1 Volume:7 Page:44-51
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Dehbi Hakim-Moulay,Mallick Ujjal,Wadsley Jonathan,Newbold Kate,Harmer Clive,Hackshaw Allan

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference34 articles.

1. Current thyroid cancer trends in the United States;Davies;JAMA Otolaryngol Head Neck Surg,2014

2. Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer;Mallick;N Engl J Med,2012

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐Term Outcome of Low‐ and High‐Dose Radioiodine for Thyroid Remnant Ablation;Clinical Endocrinology;2024-09-04

2. Comparison of 8th and 7th editions of TNM staging in terms of mortality, persistent disease, and response to treatment in patients with differentiated thyroid cancer;Nuklearmedizin - NuclearMedicine;2024-07-10

3. Radioactive iodine therapy for thyroid cancer coexisting with Hashimoto’s thyroiditis: a systematic review and meta-analysis;British Journal of Radiology;2024-06-13

4. Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part I. Initial Management of Differentiated Thyroid Cancers - Chapter 6. Radioactive Iodine Treatment after Thyroidectomy 2024;International Journal of Thyroidology;2024-05-30

5. Ablation Rates and Long-Term Outcome Following Low-Dose Radioiodine for Differentiated Thyroid Cancer in the West of Scotland: A Retrospective Analysis;Endocrine Practice;2024-04